Compare KRO & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRO | AVNS |
|---|---|---|
| Founded | 1916 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.9M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | KRO | AVNS |
|---|---|---|
| Price | $4.49 | $11.24 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | 299.8K | ★ 511.6K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,864,200,000.00 | $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | $6.29 | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.01 | ★ 2.70 |
| 52 Week Low | $4.08 | $9.30 |
| 52 Week High | $10.71 | $19.00 |
| Indicator | KRO | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 46.12 |
| Support Level | $4.65 | $11.05 |
| Resistance Level | $4.96 | $12.34 |
| Average True Range (ATR) | 0.26 | 0.45 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 22.03 | 26.67 |
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.